Recombinant Escherichia coli O127:H6 UPF0410 protein ymge (ymgE)

Shipped with Ice Packs
In Stock

Description

Structure and Sequence

The ymge protein is a full-length, 84-amino-acid (aa) polypeptide (UniProt ID: P58767) derived from E. coli O127:H6, a pathogenic strain associated with enteropathogenic E. coli (EPEC). Key structural features include:

  • N-terminal His-tag: Facilitates purification via immobilized metal affinity chromatography (IMAC) .

  • Primary Sequence:
    MGIIAWIIFGLIAGIIAKLIMPGRDGGGFFLTCILGIVGAVVGGWLATMFGIGGSISGFN LHSFLVAVVGAILVLGVFRLLQRE .
    (Note: Minor sequence variations exist across strains, such as MGIIAWIIFDLIAGIIAKLIMPGRDGGGFFLTCILGIVGAVVGGWLATMFGIGGSISGFN LHSFLVAVVGAILVLGIFRLLRRE in non-O127 strains .)

  • Secondary Structure: Predicted to contain transmembrane helices, consistent with hypothetical roles in membrane-associated processes .

Functional Annotations:

FeatureDescription
Gene NameymgE (synonyms: tag, E2348C_1314)
Protein FamilyUPF0410 family; GlsB/YeaQ/YmgE family (stress response membrane proteins)
Subcellular LocalizationInner membrane (predicted)

Production and Purification

The protein is heterologously expressed in E. coli using optimized vectors, with the following specifications:

ParameterDetails
HostE. coli
Expression SystempET-based plasmids with T7 promoter
Purity>85% (SDS-PAGE) ; >90% (optimized protocols)
Storage BufferTris/PBS-based buffer with 6% trehalose, pH 8.0
ReconstitutionSterile water (0.1–1.0 mg/mL), with 50% glycerol for long-term storage

Key Production Steps:

  1. Cloning: Full-length ymgE gene inserted into expression vectors.

  2. Expression: Induced via IPTG; protein accumulates in inclusion bodies .

  3. Purification: Denaturation in urea, refolding, and IMAC chromatography .

Immunological Studies

  • Antibody Development: Used as an antigen to generate polyclonal antibodies for ELISA and Western blotting .

    • Reactivity: Specific to E. coli O127:H6 (strain E2348/69/EPEC) .

    • Applications: Detection of ymge in pathogenic strains or vaccine development .

Functional Characterization

  • Membrane Protein Interactions: Hypothetical involvement in stress response or transmembrane signaling .

  • Capsule Secretion: While not directly linked to group 4 capsule proteins (e.g., GfcD ), UPF0410 family proteins may interact with secretion systems .

  • Tag Variations: N-terminal His-tag (standard), but other tags (e.g., GST) may be available upon request .

  • Buffer Additives: Glycerol (50%) or trehalose to enhance stability .

Research Gaps and Future Directions

While structural and immunological data are emerging, critical gaps remain:

  • Functional Role: Limited evidence for ymge’s involvement in pathogenesis or stress response.

  • Interactome: No confirmed interactions with other proteins (e.g., GfcB/C/D ).

  • Therapeutic Potential: Unexplored as a vaccine candidate or drug target.

Product Specs

Form
Supplied as a lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and agreed upon in advance (incurring additional charges).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its implementation.
Synonyms
ymgE; tag; E2348C_1314; UPF0410 protein YmgE; Transglycosylase-associated gene protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-84
Protein Length
full length protein
Species
Escherichia coli O127:H6 (strain E2348/69 / EPEC)
Target Names
ymgE
Target Protein Sequence
MGIIAWIIFGLIAGIIAKLIMPGRDGGGFFLTCILGIVGAVVGGWLATMFGIGGSISGFN LHSFLVAVVGAILVLGVFRLLQRE
Uniprot No.

Target Background

Database Links
Protein Families
UPF0410 family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is Recombinant Escherichia coli O127:H6 UPF0410 protein ymgE?

Recombinant Escherichia coli O127:H6 UPF0410 protein ymgE (ymgE) is a full-length protein (1-84 amino acids) that is commonly expressed with an N-terminal His tag in E. coli expression systems. It belongs to the UPF0410 protein family and is also known as Transglycosylase-associated gene protein. The protein has a UniProt ID of P58767 and is typically studied in the context of bacterial membrane biology and cellular functions .

The recombinant version allows researchers to study the protein's structure-function relationships through isolation and purification techniques that maintain its native conformation while providing sufficient quantities for comprehensive experimental analysis. Unlike endogenously expressed ymgE, the recombinant version offers advantages in terms of yield, purity, and the ability to introduce specific modifications for research purposes.

What are the recommended storage and handling conditions for recombinant ymgE protein?

For optimal stability and activity of recombinant ymgE protein, the following storage and handling conditions are recommended:

ParameterRecommended ConditionNotes
Storage Temperature-20°C/-80°CAliquoting is necessary for multiple use
Storage BufferTris/PBS-based buffer with 6% Trehalose, pH 8.0Maintains protein stability
ReconstitutionDeionized sterile water to 0.1-1.0 mg/mLBrief centrifugation prior to opening is recommended
Long-term StorageAdd 5-50% glycerol (final concentration)Default final concentration of 50% glycerol
Usage NotesAvoid repeated freeze-thaw cyclesStore working aliquots at 4°C for up to one week

Proper aliquoting and storage are critical for maintaining protein integrity, as repeated freeze-thaw cycles can lead to protein denaturation and loss of activity . When planning experiments, researchers should consider preparing appropriately sized aliquots based on their experimental design to minimize freeze-thaw events.

How should I design experiments to investigate ymgE protein function?

When designing experiments to investigate ymgE protein function, consider implementing a parallel experimental design approach that allows for robust identification of causal mechanisms. This approach involves conducting two parallel experiments:

In the first experiment, manipulate only the expression or activity of ymgE protein (treatment variable) while measuring downstream effects (outcome variables). In the second experiment, simultaneously manipulate both ymgE expression/activity and a potential mediator of its effects .

This parallel design offers several advantages:

  • It enables identification of direct effects of ymgE protein on cellular processes

  • It allows determination of mechanistic pathways through which ymgE exerts its effects

  • It provides greater identification power than single-experiment designs

When implementing this approach, carefully consider the following:

  • Define clear, measurable outcomes related to ymgE function

  • Ensure that manipulation of any mediator doesn't affect outcomes through pathways other than the intended mediator (consistency assumption)

  • Include appropriate controls to account for potential confounding variables

  • Randomize experimental units across treatment conditions to minimize bias

What experimental controls are essential when working with recombinant ymgE protein?

Essential experimental controls when working with recombinant ymgE protein include:

  • Negative Controls:

    • Vector-only expression control (cells transformed with empty vector)

    • Inactive protein control (mutated ymgE with altered key residues)

    • Buffer-only control (without protein) for binding or activity assays

  • Positive Controls:

    • Well-characterized membrane protein with known function

    • Previously validated interaction partners if studying protein-protein interactions

    • Known modulators of pathways potentially affected by ymgE

  • Technical Controls:

    • Verification of protein expression and purity via SDS-PAGE

    • Confirmation of His-tag presence and functionality

    • Assessment of protein folding and stability under experimental conditions

  • Biological Validation Controls:

    • Complementation studies in ymgE-deficient strains

    • Dose-response relationships to establish specificity

    • Cross-validation using alternative tags or expression systems

These controls help distinguish specific ymgE-mediated effects from artifacts related to the recombinant nature of the protein or experimental system limitations. They also provide benchmarks for assessing experimental quality and reproducibility across different batches of protein and experimental replicates.

How can I apply causal mechanism frameworks to study ymgE-mediated processes?

To apply causal mechanism frameworks to study ymgE-mediated processes, you should consider implementing experimental designs that can effectively distinguish between direct effects and mediated effects. The following approach is recommended:

  • Formulate clear causal questions:

    • Does ymgE directly affect cellular process X?

    • Is the effect of ymgE on outcome Y mediated through intermediate Z?

    • What proportion of ymgE's total effect occurs through specific pathways?

  • Consider advanced experimental designs:

    • Implement a crossover design where experimental units are sequentially assigned to different experiments with careful manipulation of both ymgE (treatment) and potential mediators

    • Use encouragement designs when direct manipulation of mediators is challenging, employing indirect and subtle manipulations that enhance the credibility of the consistency assumption

  • Statistical approaches:

    • Apply mediation analysis techniques to quantify direct and indirect effects

    • Use structural equation modeling to test hypothesized causal pathways

    • Consider counterfactual frameworks to estimate causal effects under different scenarios

  • Validation strategies:

    • Test alternative causal models with the same data

    • Conduct sensitivity analyses to assess robustness to violations of assumptions

    • Triangulate findings using different experimental approaches and analytical methods

By employing these approaches, you can move beyond mere associations to establish causal relationships between ymgE activity and downstream biological processes, providing deeper mechanistic insights into the protein's function .

How should I handle unexpected data that contradicts my hypothesis about ymgE function?

When confronted with data that contradicts your hypothesis about ymgE function, follow these methodological steps:

  • Rigorous data verification:

    • Examine all data thoroughly to identify any discrepancies or unusual patterns

    • Compare your findings with existing literature on ymgE and related proteins

    • Verify experimental procedures, reagent quality, and equipment calibration

  • Critical evaluation of assumptions:

    • Reassess your initial assumptions about ymgE's function or mechanism

    • Consider whether the experimental design adequately tests your hypothesis

    • Evaluate whether your controls adequately account for confounding factors

  • Alternative explanation exploration:

    • Generate alternative hypotheses that could explain the contradictory results

    • Consider whether ymgE might have dual or context-dependent functions

    • Assess whether experimental conditions might have activated compensatory mechanisms

  • Methodological refinement:

    • Modify your data collection approaches if methodological issues are identified

    • Refine variable definitions and implement additional experimental controls

    • Consider different analytical techniques that might reveal patterns not initially apparent

  • Embrace scientific opportunity:

    • Recognize that contradictory results often lead to important discoveries

    • Document unexpected findings thoroughly for potential novel insights

    • Design targeted follow-up experiments to specifically investigate the contradiction

Remember that unexpected results are valuable components of the scientific process that often lead to significant advances in understanding. Thoroughly documenting and investigating contradictory findings regarding ymgE function may reveal important aspects of its biology that were previously unrecognized .

What statistical approaches are most appropriate for analyzing ymgE protein interaction data?

When analyzing ymgE protein interaction data, several statistical approaches can be employed depending on the experimental design and data characteristics:

  • For direct protein-protein interaction studies:

    • Apply co-immunoprecipitation statistical analysis using enrichment ratios

    • Calculate binding affinity parameters (Kd values) from concentration-dependent binding data

    • Use statistical tests like Student's t-test or ANOVA with post-hoc tests to compare interaction strengths across conditions

  • For high-throughput interaction screening:

    • Implement false discovery rate (FDR) correction for multiple comparisons

    • Use probability-based scoring systems for mass spectrometry data

    • Apply machine learning algorithms to identify true interactions from background

  • For functional interaction studies:

    • Employ regression models to quantify relationships between ymgE levels and functional outputs

    • Use mediation analysis to identify causal pathways through which ymgE influences cellular processes

    • Apply structural equation modeling for complex interaction networks

  • For comparative studies:

    • Utilize phylogenetic methods to analyze evolutionary conservation of interactions

    • Implement meta-analytical approaches to integrate findings across multiple studies

    • Apply Bayesian frameworks to update interaction probabilities based on new evidence

When reporting results, always include:

  • Effect sizes with confidence intervals

  • Precise p-values rather than threshold reporting

  • Statistical power calculations

  • Validation of statistical assumptions (normality, independence, etc.)

These statistical approaches help distinguish biologically meaningful interactions from experimental noise and provide quantitative frameworks for understanding the functional significance of ymgE protein interactions.

What are common challenges in recombinant ymgE protein expression and purification?

Researchers frequently encounter several challenges when expressing and purifying recombinant ymgE protein:

  • Expression challenges:

    • Low expression levels due to ymgE's membrane protein nature

    • Protein toxicity to host cells when overexpressed

    • Formation of inclusion bodies containing misfolded protein

    • Inconsistent expression levels between batches

  • Purification challenges:

    • Difficulty in solubilizing membrane-associated ymgE without denaturing

    • Non-specific binding of contaminants to purification resins

    • Loss of protein during buffer exchange or concentration steps

    • Protein aggregation after removal from detergent environment

  • Methodological solutions:

    • Optimize expression conditions (temperature, inducer concentration, expression time)

    • Test multiple detergents for optimal solubilization (e.g., DDM, CHAPS, Triton X-100)

    • Use gradient elution protocols to improve His-tag purification specificity

    • Incorporate stabilizing agents (glycerol, specific lipids) in purification buffers

    • Consider implementing on-column refolding protocols for inclusion body recovery

  • Quality control approaches:

    • Verify protein identity using mass spectrometry

    • Assess purity using SDS-PAGE (>90% purity is typically desirable)

    • Confirm proper folding using circular dichroism or limited proteolysis

    • Evaluate functional activity using appropriate binding or activity assays

When troubleshooting, systematic modification of expression and purification parameters while maintaining careful documentation of outcomes can help identify optimal conditions for your specific experimental system and requirements.

How can I verify the structural integrity of purified recombinant ymgE protein?

Verifying the structural integrity of purified recombinant ymgE protein is crucial for ensuring experimental reliability. Several complementary approaches can be employed:

A comprehensive verification approach should include multiple complementary methods, as no single technique can unequivocally confirm structural integrity. Results should be interpreted in the context of ymgE's membrane protein nature, which often presents unique structural characteristics compared to soluble proteins.

How can I design experiments to study the role of ymgE in bacterial membrane dynamics?

To study the role of ymgE in bacterial membrane dynamics, design experiments that combine genetic manipulation, biophysical measurements, and functional assays:

  • Genetic manipulation approaches:

    • Create ymgE knockout strains using CRISPR-Cas9 or homologous recombination

    • Develop inducible expression systems to control ymgE levels

    • Generate point mutations in key residues identified in the amino acid sequence (e.g., targeting the hydrophobic regions: MGIIAWIIFGLIAGIIAKLIMPGRDGGGFFLTCILGIVGAVVGGWLATMFGIGGSISGFNLHSFLVAVVGAILVLGVFRLLQRE)

    • Create fluorescently tagged versions for localization studies

  • Membrane biophysical measurements:

    • Assess membrane fluidity using fluorescence anisotropy or FRAP (Fluorescence Recovery After Photobleaching)

    • Measure membrane potential changes using voltage-sensitive dyes

    • Evaluate membrane permeability through leakage assays

    • Quantify membrane curvature or morphology using electron microscopy

  • Functional assays:

    • Monitor changes in membrane protein organization using FRET-based proximity assays

    • Assess impact on membrane-dependent processes (transport, signaling, division)

    • Measure susceptibility to membrane-targeting antimicrobials

    • Evaluate stress responses related to membrane integrity

  • Advanced experimental designs:

    • Implement parallel design experiments to identify causal relationships between ymgE activity and membrane properties

    • Use crossover design approaches to examine sequential effects of ymgE perturbation

    • Apply encouragement designs when direct manipulation of membrane properties is challenging

  • Data integration:

    • Correlate structural features of ymgE with observed functional effects

    • Map interaction networks between ymgE and other membrane components

    • Develop computational models that predict ymgE's impact on membrane dynamics

This multi-faceted approach allows for comprehensive characterization of ymgE's role in membrane dynamics while providing robust evidence for causal relationships between the protein and specific membrane properties or functions.

What approaches can be used to identify potential interaction partners of ymgE protein?

Identifying potential interaction partners of ymgE protein requires a multi-dimensional approach combining in vitro, in vivo, and computational methods:

  • In vitro biochemical approaches:

    • Pull-down assays using His-tagged recombinant ymgE as bait

    • Co-immunoprecipitation with antibodies against ymgE or its tag

    • Crosslinking mass spectrometry to capture transient interactions

    • Surface plasmon resonance (SPR) or bio-layer interferometry to validate direct interactions

    • Proximity labeling with BioID or APEX2 fused to ymgE

  • In vivo approaches:

    • Bacterial two-hybrid or split-GFP complementation assays

    • In situ crosslinking followed by mass spectrometry identification

    • Fluorescence resonance energy transfer (FRET) with tagged protein pairs

    • Co-localization studies using fluorescence microscopy

    • Genetic interaction screens (synthetic lethality or suppressor screens)

  • Computational prediction methods:

    • Sequence-based interaction prediction using machine learning algorithms

    • Structural docking simulations if structural data is available

    • Network analysis based on gene co-expression patterns

    • Phylogenetic profiling to identify proteins with similar evolutionary patterns

    • Text mining of scientific literature for potential associations

  • Data integration and validation:

    • Score interactions based on evidence from multiple independent methods

    • Validate high-confidence interactions with reciprocal pull-downs

    • Assess biological relevance through functional assays

    • Map interaction networks and contextualize within known pathways

When reporting identified interaction partners, include confidence scores, experimental conditions, and biological context to facilitate interpretation of results. Particularly focus on interactions that occur in physiologically relevant contexts, as in vitro detection does not necessarily indicate functional significance in vivo.

How can I apply parallel experimental designs to study causal mechanisms involving ymgE?

To apply parallel experimental designs for studying causal mechanisms involving ymgE, implement the following structured approach:

  • Experimental structure setup:

    • Randomly divide your experimental units (e.g., bacterial cultures, cell lines) into two parallel experiments

    • In the first experiment, randomize only the treatment variable (ymgE expression/activity)

    • In the second experiment, simultaneously randomize both the treatment (ymgE) and potential mediator variables

  • Implementation strategy:

    • First experiment: Manipulate ymgE levels (e.g., using inducible promoters) and measure both the mediator (e.g., membrane fluidity) and outcome variables (e.g., antibiotic resistance)

    • Second experiment: Independently manipulate both ymgE levels and the mediator (e.g., using chemical modulators of membrane fluidity) and measure the outcome variables

  • Key considerations:

    • Ensure that mediator manipulation is consistent with the consistency assumption (manipulation should not affect the outcome through pathways other than the mediator)

    • When direct manipulation is challenging, consider parallel encouragement designs where subjects are randomly encouraged to take certain values of the mediator

    • For membrane proteins like ymgE, indirect manipulations might be more appropriate to maintain system integrity

  • Analysis approach:

    • Compare outcomes between the two experimental designs to identify direct and indirect effects

    • Quantify the proportion of ymgE's total effect that operates through the hypothesized mediator

    • Test alternative models with different potential mediators to identify the most significant pathways

  • Validation and extension:

    • Implement crossover designs as complementary approaches, where experimental units are sequentially assigned to different treatments

    • Consider sequential testing of multiple potential mediators to map complete causal pathways

    • Validate findings using independent methodological approaches

This parallel design approach significantly improves identification power compared to single-experiment designs, allowing researchers to disentangle complex causal mechanisms involving ymgE in bacterial physiology and function .

What emerging technologies could advance our understanding of ymgE protein function?

Several cutting-edge technologies show promise for advancing our understanding of ymgE protein function:

  • Advanced structural biology approaches:

    • Cryo-electron microscopy for high-resolution structural determination without crystallization

    • Integrative structural biology combining multiple data sources (NMR, crosslinking MS, etc.)

    • Hydrogen-deuterium exchange mass spectrometry for dynamic structural analysis

    • Single-molecule FRET to track conformational changes in real-time

  • Genetic and genomic technologies:

    • CRISPR interference (CRISPRi) for precise temporal control of ymgE expression

    • Massively parallel reporter assays to characterize regulatory elements controlling ymgE

    • Single-cell transcriptomics to capture heterogeneous responses to ymgE perturbation

    • Nanopore sequencing for direct detection of modified nucleotides affecting ymgE expression

  • Imaging innovations:

    • Super-resolution microscopy (PALM/STORM) for visualizing ymgE organization in membranes

    • Label-free imaging techniques like Raman microscopy for monitoring membrane composition

    • Correlative light and electron microscopy (CLEM) to link ymgE localization with membrane ultrastructure

    • Live-cell imaging with genetically encoded biosensors to track ymgE-dependent processes

  • Computational approaches:

    • AlphaFold2 or RoseTTAFold for accurate structure prediction of ymgE and complexes

    • Molecular dynamics simulations of ymgE within bacterial membrane environments

    • Machine learning for prediction of functional sites and interaction partners

    • Systems biology modeling of ymgE's role in broader cellular networks

  • Functional screening methods:

    • CRISPR-based genetic interaction maps to position ymgE in functional pathways

    • Activity-based protein profiling to identify substrates or binding partners

    • Microfluidic platforms for high-throughput phenotypic screening

    • In situ approaches to study ymgE function in native environments

Combining these technologies within well-designed experimental frameworks will likely yield significant insights into ymgE's structure-function relationships, membrane interactions, and physiological roles in bacterial cells.

How might we apply findings from ymgE research to broader bacterial membrane biology?

Findings from ymgE research can be applied to broader bacterial membrane biology through several translational approaches:

  • Comparative analysis across bacterial species:

    • Identify ymgE homologs across diverse bacterial taxa to trace evolutionary conservation

    • Compare membrane localization and function of ymgE-like proteins across species

    • Assess whether ymgE represents a paradigm for a broader class of membrane proteins

    • Use conservation patterns to identify functionally important domains or residues

  • Integration with membrane organization models:

    • Incorporate ymgE structural and functional data into models of bacterial membrane domains

    • Evaluate ymgE's role in membrane compartmentalization or protein clustering

    • Assess contribution to membrane asymmetry or curvature generation

    • Determine impact on membrane physical properties (fluidity, permeability, stiffness)

  • Relevance to membrane stress responses:

    • Examine ymgE's involvement in adaptation to environmental stressors

    • Investigate potential roles in antibiotic resistance mechanisms

    • Assess contribution to membrane repair or remodeling processes

    • Determine importance during bacterial growth phase transitions

  • Methodological advances:

    • Apply successful ymgE purification and characterization protocols to other challenging membrane proteins

    • Extend experimental designs used for ymgE (parallel, crossover) to study other membrane protein mechanisms

    • Develop improved membrane protein expression systems based on ymgE experiences

    • Create new tools for membrane protein visualization or manipulation

  • Therapeutic implications:

    • Evaluate ymgE as a potential antimicrobial target in pathogenic E. coli strains

    • Assess whether disrupting ymgE function impacts bacterial virulence or persistence

    • Investigate small molecule modulators of ymgE as potential antimicrobial agents

    • Determine whether ymgE function correlates with antibiotic susceptibility profiles

By positioning ymgE research within this broader context, findings can contribute to fundamental understanding of bacterial membrane biology while potentially opening new avenues for antimicrobial development and bacterial adaptation mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.